TerSera Therapeutics LLC
acquired/licensed specialty pharmaceuticals (oncology, rare disease, non-opioid pain)
Privately held: no public share price · United States
Assets
(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | GnRH receptor (agonist)Peptide | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
margetuximab(Margenza) | Approved | HER2Monoclonal antibody | Breast Cancer HER2-Positive Breast Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.